Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119099465 | 11909946 | 5 | F | 20121209 | 20160629 | 20160112 | 20160705 | EXP | PHHY2012DE118165 | NOVARTIS | 0.00 | E | M | Y | 0.00000 | 20160706 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119099465 | 11909946 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 210 | MG | Y | U | 22334 | 10 | MG | QD | |||
| 119099465 | 11909946 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG | 0 | 10 | MG | ||||||||
| 119099465 | 11909946 | 3 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 2.5 MG | 0 | 2.5 | MG | ||||||||
| 119099465 | 11909946 | 4 | C | TORASEMID | TORSEMIDE | 1 | Unknown | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 119099465 | 11909946 | 5 | C | TORASEMID | TORSEMIDE | 1 | 0 | ||||||||||||
| 119099465 | 11909946 | 6 | C | MOLSIDOMIN | 2 | Unknown | 8 MG, UNK | 0 | 8 | MG | |||||||||
| 119099465 | 11909946 | 7 | C | ACTRAPHANE | INSULIN HUMAN | 1 | Unknown | 0 | |||||||||||
| 119099465 | 11909946 | 8 | C | MARCUMAR | PHENPROCOUMON | 1 | Unknown | 0 | |||||||||||
| 119099465 | 11909946 | 9 | C | ACTRAPID | INSULIN HUMAN | 1 | Unknown | 100 OT, UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119099465 | 11909946 | 1 | Metastatic renal cell carcinoma |
| 119099465 | 11909946 | 2 | Hypertension |
| 119099465 | 11909946 | 3 | Hypertension |
| 119099465 | 11909946 | 4 | Cardiac failure congestive |
| 119099465 | 11909946 | 5 | Cardiac failure |
| 119099465 | 11909946 | 6 | Angina pectoris |
| 119099465 | 11909946 | 7 | Diabetes mellitus |
| 119099465 | 11909946 | 8 | Atrial fibrillation |
| 119099465 | 11909946 | 9 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119099465 | 11909946 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119099465 | 11909946 | Blood calcium decreased | |
| 119099465 | 11909946 | C-reactive protein increased | |
| 119099465 | 11909946 | Dyspnoea | |
| 119099465 | 11909946 | General physical health deterioration | |
| 119099465 | 11909946 | Pleural effusion | |
| 119099465 | 11909946 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119099465 | 11909946 | 1 | 20121119 | 20121209 | 0 | |
| 119099465 | 11909946 | 2 | 20100101 | 0 | ||
| 119099465 | 11909946 | 3 | 20060501 | 0 | ||
| 119099465 | 11909946 | 4 | 2003 | 0 | ||
| 119099465 | 11909946 | 6 | 2003 | 0 | ||
| 119099465 | 11909946 | 7 | 20031020 | 0 | ||
| 119099465 | 11909946 | 8 | 20031020 | 0 | ||
| 119099465 | 11909946 | 9 | 20121221 | 20121222 | 0 |